FindTrial
Sign In

Study on the clinical efficacy of complete adenomyomectomy for patients with adenomyosis

Study on the clinical efficacy of complete adenomyomectomy for patients with adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075228
Enrollment
Unknown
Registered
2023-08-30
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomyosis

Interventions

complete adenomyomectomy:NA

Sponsors

Obstetrics & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1)Patients who were premenopausal with adenomyosis, 2) patients with dysmenorrhea or menorrhagia; 3) patients with a desire to preserve the uterus.

Exclusion criteria

Exclusion criteria: There is no obvious adenomyosis lesion evaluated by MRI, drug treatment is effective, there is a recent need for fertility, and IVF is evaluated feasible by the reproductive department.

Design outcomes

Primary

MeasureTime frame
visual analogue scale(VAS);menstrual amount;—

Secondary

MeasureTime frame
hemoglobin;Uterine volume;CA125; platelet count;—

Countries

China

Contacts

Public ContactXishi Liu

Obstetrics & Gynecology Hospital of Fudan University

lxsdoc@hotmail.com+86 133 1166 6000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026